COX-2 and its downstream metabolite PGE2 are enriched in invasive BC, including IBC (39, 48), and COX-2 expression mostly correlates with ER– status, advanced disease, and shorter survival probability (42). This evidence concerns the gene PTGS2 and breast cancer.